Literature DB >> 3215724

Parkinson's disease: an autoimmune process.

R A Barker1, A P Cahn.   

Abstract

Parkinson's disease (PD) is a common condition that, in the majority of cases, is idiopathic in origin. The loss of central dopaminergic pathways is well-known and in this paper a theory is presented that this is brought about by an autoimmune process. The lack of any HLA association or familial clumping for the disease does not exclude such a theory, as a common etiological agent may exist that we do not yet recognize, e.g., infection, or drugs. Several autoantibodies and disturbances in T-cell function have been found in PD. The theory proposes that the production of autoantibodies and T-cell activation are important in the pathogenesis of idiopathic PD by an action on the substance P striatonigral pathway and its input to the dopaminergic nigrostriatal pathway. The autoimmune destruction of the substance P input leads to a secondary loss of the dopaminergic system and hence PD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215724     DOI: 10.3109/00207458808985773

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  7 in total

Review 1.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

2.  Presenting mitochondrial antigens: PINK1, Parkin and MDVs steal the show.

Authors:  Rosalind F Roberts; Edward A Fon
Journal:  Cell Res       Date:  2016-09-02       Impact factor: 25.617

3.  CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.

Authors:  Jessica A Hutter Saunders; Katherine A Estes; Lisa M Kosloski; Heather E Allen; Kathryn M Dempsey; Diego R Torres-Russotto; Jane L Meza; Pamela M Santamaria; John M Bertoni; Daniel L Murman; Hesham H Ali; David G Standaert; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-11       Impact factor: 4.147

4.  Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.

Authors:  Ignacio Riquelme Medina; Zelmina Lubovac-Pilav
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

Review 5.  Gut microbiota: Implications in Parkinson's disease.

Authors:  Arun Parashar; Malairaman Udayabanu
Journal:  Parkinsonism Relat Disord       Date:  2017-02-07       Impact factor: 4.891

Review 6.  Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities.

Authors:  Ovidiu-Dumitru Ilie; Alin Ciobica; Jack McKenna; Bogdan Doroftei; Ioannis Mavroudis
Journal:  Oxid Med Cell Longev       Date:  2020-02-05       Impact factor: 6.543

7.  Co-expression Network Analysis Reveals Key Genes Related to Ankylosing spondylitis Arthritis Disease: Computational and Experimental Validation.

Authors:  Leila Najafzadeh; Mahdi Mahmoudi; Mostafa Ebadi; Marzieh Dehghan Shasaltaneh
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.